𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Spigel, D. R.; Ervin, T. J.; Ramlau, R. A.; Daniel, D. B.; Goldschmidt, J. H.; Blumenschein, G. R.; Krzakowski, M. J.; Robinet, G.; Godbert, B.; Barlesi, F.; Govindan, R.; Patel, T.; Orlov, S. V.; Wertheim, M. S.; Yu, W.; Zha, J.; Yauch, R. L.; Patel, P. H.; Phan, S.-C.; Peterson, A. C.


Book ID
125511055
Publisher
American Society of Clinical Oncology
Year
2013
Tongue
English
Weight
266 KB
Volume
31
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES